Drug & Medication Database

11 DESCRIPTION CINQAIR (reslizumab) is a humanized interleukin-5 antagonist monoclonal antibody (IgG4κ). Reslizumab is produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. Reslizumab has a molecular weight of approximately 147 kDa. CINQAIR is a sterile, preservative-free, clear to slightly hazy/opalescent, colorless to slightly yellow solution (injection) for intravenous infusion.

Brands: Cinqair

11 DESCRIPTION REZDIFFRA (resmetirom) tablets contain resmetirom, a thyroid hormone receptor-beta agonist. The chemical name for REZDIFFRA is 2-[3,5-Dichloro-4-((6-oxo-5-(propan-2-yl)-1,6-dihydropyridazin-3-yl)oxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile. The molecular formula is C 17 H 12 Cl 2 N 6 O 4 and the molecular weight is 435.22. The chemical structure is: Resmetirom has low aqueous solubility below pH 6 and higher solubility above pH 7 (0.44 mg/mL at pH 7.04).

Brands: Rezdiffra

Purpose Acne treatment ointment

Brands: Adult Acnomel

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Respiratory Syncytial Virus Nosode 4033

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Route: INTRAMUSCULAR. Active ingredients: RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN (.06 mg/.5mL); RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN (.06 mg/.5mL). Category: BLA.

Brands: Abrysvo

Dosage form: KIT. Category: BLA.

Brands: Arexvy

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Restless Leg Drops 2172

Purpose Acne Treatment

Brands: Aha/bha Swipes

Dosage form: POWDER. Active ingredients: RESVERATROL (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Bladder 7006

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Gallbladder 7007

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Heart 7009

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Kidney 7005

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Large Intestine 7004

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Liver 7008

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Lung 7003

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Pituitary/sex 7012

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Small Intestine 7010

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Spirit/metaphysical 7013

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Spleen/pancreas 7002

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Stomach 7001

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Ret Thyroid/adrenal 7011

Manufactured by ALMIRALL. Dosage form: OINTMENT. Route: TOPICAL. Active ingredients: RETAPAMULIN (1%). Application: NDA022055.

Dosage form: POWDER. Active ingredients: RETATRUTIDE (1 g/g). Category: BULK INGREDIENT.

Dosage form: SOLUTION. Active ingredients: RETEPLASE (1 g/g). Category: BULK INGREDIENT.

USES Helps prevent sunburn. If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Brands: Retexturizing Primer Broad Spectrum Spf 20

Dosage form: SOLUTION. Active ingredients: RETIFANLIMAB (25 mg/mL). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION Retifanlimab-dlwr is a programmed death receptor-1 (PD-1)–blocking antibody. Retifanlimab‑dlwr is a humanized IgG4 kappa monoclonal antibody produced in Chinese hamster ovary cells. Retifanlimab-dlwr has an approximate molecular weight of 148 kDa. ZYNYZ (retifanlimab-dlwr) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to pale yellow solution for intravenous use. The solution is free from visible particles.

Brands: Zynyz

Topical analgesic

Brands: Pain

11 DESCRIPTION ENCELTO (revakinagene taroretcel-lwey) implant, is single-dose, sterile, nonpyrogenic and retrievable. ENCELTO is an allogeneic encapsulated cell-based gene therapy that contains 200,000 to 440,000 allogeneic retinal pigment epithelial cells expressing recombinant human ciliary neurotrophic factor (rhCNTF) (NTC-201-6A cell line) for surgical intravitreal placement.

Brands: Encelto